CClinicalTrials.gg
CompletedNCT06575855IASTMUpdated Aug 28, 2024

Comparative Effectivenes of IASTM and MET on Post Operative Elbow Stiffness

An interventional study of IASTM and METS in Elbow Stiffness, sponsored by University of Faisalabad. Completed at 1 site in Pakistan. Open to participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-28.

Sponsored by University of Faisalabad · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2024, registered Aug 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Study summary

This study is basically for the evaluation of comparative effectiveness of instrument assisted soft tissue mobilization IASTM and muscle energy technique MET on Post operative , Randomized clinical trial .

Read the detailed description

In this study 28 participants including, which is further devided into two groups,14 in each group which is named as Group A,and Group B respectively.these groups are randomly allocated and give them intervention.which is instrument assisted soft tissue mobilization IASTM given to Group A and muscle energy technique MET given to Group B,then compare the effectiveness of both groups on Post operative elbow stiffness, duration of protocol is basically for 2,3 weeks depending upon patient condition and present situation.

02

Conditions studied

  • Elbow Stiffness

Keywords

  • Post operative elbow stiffness, MET, IASTM
03

In context

Lead sponsor

University of Faisalabad is the lead sponsor of 83 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • gender both Age:30 to 50 years Who fullfil concent form

Exclusion criteria

Exclusion Criteria:

  • other than inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Active comparator
    Group A

    Group A received IASTM as treatment protocol

    Other: IASTM

  • Active comparator
    Group B

    Group B received METs as a treatment protocol

    Other: METS

Interventions

  • OtherIASTM

    Group A received IASTM by using Graston Tool

  • OtherMETS

    Group B received METs

06

What researchers measure

Primary outcomes

  1. VAS and goniometer

    Visual analog scaleThe Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain) and universal goniometer to measure the range of motion, an instrument that measures angle motion at a joint.

    Time frame: 4 months

Secondary outcomes

  1. DASH questionaire

    The disabilities of the arm, shoulder and hand (DASH) questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The DASH consists mainly of a 30-item disability/symptom scale, scored 0 (no disability) to 100

    Time frame: 4 months

07

Study locations

1 site
  • Nayyab Goher
    Faisalābad, Punjab, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06575855
Lead sponsor
University of Faisalabad
Collaborators
University of Sargodha
Responsible party
Nayyab Goher (Student, University of Faisalabad) — Principal investigator
First posted
Aug 28, 2024
Start date
Feb 17, 2024
Primary completion
Apr 17, 2024
Completion
Jun 17, 2024
Last update
Aug 28, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion